Cyclo Therapeutics Inc (CYTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,638 | 960 | 1,270 | 2,134 | 1,079 |
| Receivables | 223 | 90 | 124 | 81 | 108 |
| Inventories | 500 | 497 | 595 | 617 | 622 |
| Other current assets | 96 | 88 | 29 | 38 | 65 |
| TOTAL | $2,457 | $1,636 | $2,019 | $2,869 | $1,873 |
| Non-Current Assets | |||||
| PPE Net | 26 | 30 | 34 | 1,810 | 1,857 |
| Other Non-Current Assets | 195 | 203 | 1,182 | 292 | 301 |
| TOTAL | $221 | $233 | $1,215 | $2,102 | $2,158 |
| Total Assets | $2,678 | $1,869 | $3,234 | $4,972 | $4,031 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 4 |
| Accounts payable and accrued liabilities | 221 | 343 | 268 | 434 | 282 |
| TOTAL | $221 | $343 | $876 | $1,123 | $991 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $221 | $343 | $876 | $1,123 | $991 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 729 | 727 | 670 | 668 | 588 |
| Common Shares | 7 | 7 | 7 | 7 | 6 |
| Retained earnings | -10,487 | -9,500 | -8,668 | -7,053 | -5,982 |
| TOTAL | $2,457 | $1,526 | $2,358 | $3,849 | $3,040 |
| Total Liabilities And Equity | $2,678 | $1,869 | $3,234 | $4,972 | $4,031 |